Trigeminal Neuralgia Clinical Trial
Official title:
Pathophysiological Mechanisms of Trigeminal Neuralgia - Neurophysiological Assessment of the Blink-reflex
This study aims to increase the understanding of the pathophysiology of trigeminal neuralgia by investigating the potential association between blink reflex abnormalities and phenotypical traits e.g. clinical characteristics and neuroimaging findings.
We hypothesize: Patients with classical trigeminal neuralgia have a prolonged latency and reduced amplitudes of the blink-reflex on the pain side compared to patients with idiopathic TN The latency and amplitudes of the blink-reflex is normal in patients with idiopathic trigeminal neuralgia Patients with concomitant persistent pain have a prolonged latency and reduced amplitudes of the blink reflex on the pain side compared to patients with pure paroxysmal TN More men than women have a prolonged latency and reduced amplitudes of the blink reflex Patients with neurovascular contact with morphological changes have prolonged latency and reduced amplitudes of the blink reflex compared to patients with simple neurovascular contact Patients with secondary TN have prolonged latency and reduced amplitudes of the blink reflex compared to patients with simple neurovascular contact Patients with neurovascular contact with morphological changes have prolonged latency and reduced amplitudes of the blink reflex on the pain side compared to the non-pain side Study population All patients with the diagnosis of primary or secondary trigeminal neuralgia, seen in the outpatient clinic at the Danish Headache Center will be screened for eligibility to participate the study. Clinical routine is not influenced by participation in this observational study. Patients will be offered the same treatment as patients not participating. Setting All patients with classic, idiopathic and symptomatic TN who have an appointment with a physician at the outpatient clinic at the Danish Headache Center as part of their work-up will, when they arrive at the center for their appointment, be asked if they want to participate in the study. The patients will be asked consecutively and there will be no prior recruitment of the patients. See recruitment below section 6.1. The study will not influence decisions regarding treatment of TN for the patients included in this protocol. Patients will be treated at the discretion of their own physician and the assessments listed below, are an integrated part of the clinical work-up and follow-up. Assessments Standardised data obtained from the medical chart The following data will be obtained and registered from the medical chart of each patient that is included in the study: Gender, date of birth, family history of TN or other facial pain Duration and localization of TN, use of and response to previous medical treatments Severity of pain at the time of examination - using Verbal Numerical Rating Scale (VNRS) Location and trigger factors for TN Previous neurosurgical treatment for TN Additional concomitant diseases and medication Type and dosage of TN related medication, if any The result of the neurological exam. Short interview on the examination day On the day of the blink reflex examination, each patient will be asked by a trained biomedical laboratory scientist, nurse or medical student about the following: Then the number of paroxysms The current level of pain (VNRS) The current dosage of TN medicine, will be on the day of neurophysiological assessments. The trained personnel will not ask about the side of pain and will not know the result of the MRI evaluation, so they are blinded in terms of side of pain and what type of TN patient they investigate. Neuroradiological assessment The 3.0 Tesla MRI, performed according to a special TN protocol will be evaluated by a neuroradiologist, blinded for pain side. The neuro imaging data will be taken from the patient electronic journal. The following data will be registered: Degree (no contact, simple contact, displacement/compression or atrophy of the nerve), location and type (arterial, venous or mixed) of NVC Neurophysiological assessment (blink-reflex) Electromyographic Recording: We want to record signals from both eyes (see image). Channel 1: left eye. Channel 2: right eye After connecting the cables to Channels 1 and 2 we can connect the electrodes to the black and red terminal wires: Black cable à active electrode: placed on the midline of the lower eyelid (orbicularis oculi muscles). Red cable à reference electrode: lateral to the eye (where the bone is superficial) We need one Green cable àground electrode: forehead or shoulder. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05152368 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy
|
Phase 1 | |
Recruiting |
NCT02801630 -
An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT02473016 -
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
|
Phase 2 | |
Recruiting |
NCT01364259 -
A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
|
Phase 3 | |
Completed |
NCT01364272 -
Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
|
||
Completed |
NCT00603694 -
Hippocampal Radiation Exposure and Memory
|
N/A | |
Completed |
NCT00913107 -
Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia
|
Phase 2/Phase 3 | |
Recruiting |
NCT04996199 -
Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial
|
Phase 4 | |
Completed |
NCT06240494 -
Predictive Factors in Maxillary and Mandibular Nerve Radiofrequency Treatment for Trigeminal Neuralgia
|
||
Completed |
NCT05712993 -
Comparative Study Between Transcoronoid and Infrazygomatic Anterior Maneuvers
|
N/A | |
Completed |
NCT04371575 -
Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients
|
||
Completed |
NCT03669744 -
Regional Anesthesia in Refractory Trigeminal Neuralgia: 21 Cases Reported to the Limoges University Hospital
|
||
Completed |
NCT05032573 -
Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia
|
N/A | |
Recruiting |
NCT05615714 -
Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04054024 -
Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia
|
Phase 2 | |
Not yet recruiting |
NCT05451251 -
Deep Brain Stimulation for Refractory Trigeminal Neuralgia With a Demyelinating Pontine Lesion
|
N/A | |
Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
Withdrawn |
NCT01932255 -
CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
|
N/A | |
Completed |
NCT05075707 -
Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 |